ArticleJACS Au2026
Rational Design of an Electronically Gated Dicyano-BODIPY Platform for Reversible-Covalent Imaging of Methylglyoxal.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reactive α-dicarbonyls, such as methylglyoxal (MGO), are critical biomarkers of carbonyl stress, yet their real-time monitoring is stifled by a selectivity-biocompatibility paradox. Existing probes either suffer from aldehyde promiscuity, failing to distinguish dicarbonyls from the global lipid peroxidation background, or rely on high-energy, cytotoxic excitation that precludes longitudinal study. Herein, we report the rational design of a dicyano-BODIPY platform engineered to resolve this tension through a precision-tuned acceptor-photoinduced electron transfer (a-PET) mechanism. By employing density functional theory (DFT) as a predictive blueprint, we strategically depressed the BODIPY core HOMO to -6.63 eV, establishing a specific energetic gradient that enforces a robust "off" state until triggered by reversible covalent capture of α-dicarbonyls. This electronically gated design enables longitudinal, visible-light imaging of bidirectional MGO flux in living cells, a feat inaccessible to current irreversible sensors. We further demonstrate the platform's high-fidelity performance in complex biological matrices by mapping dose-responsive MGO burden in murine brain tissue following controlled intracranial perturbation, providing a vital tool for interrogating the role of glyoxal stress in tissue-level pathologies. This work provides a generalizable electronic framework for the development of reversible-covalent sensors capable of monitoring metabolic dynamics in intact biological environments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.